Effect of Hemodialysis on Glaucoma Patients.

Clinical ophthalmology (Auckland, N.Z.) Pub Date : 2025-03-12 eCollection Date: 2025-01-01 DOI:10.2147/OPTH.S513421
Tina M Hendricks, Tyler S Quist, Kai Wang, Lisa M Antes, Erin A Boese
{"title":"Effect of Hemodialysis on Glaucoma Patients.","authors":"Tina M Hendricks, Tyler S Quist, Kai Wang, Lisa M Antes, Erin A Boese","doi":"10.2147/OPTH.S513421","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Prospective study to determine if patients with glaucoma are at increased risk of intraocular pressure (IOP) fluctuation and changes in ocular perfusion pressure (OPP) during hemodialysis (HD) sessions when compared to patients without glaucoma.</p><p><strong>Patients and methods: </strong>Patients undergoing HD at the University of Iowa for end-stage renal disease were recruited. Enrollment was restricted to patients undergoing standard HD sessions for a minimum of three months. Hand-held slit lamp examination, IOP, blood pressure (BP), and central corneal thickness (CCT) measures were taken at the following three time points: the beginning of the session <i>(before</i>), at the half-way point <i>(middle)</i>, and at the conclusion of the session <i>(end)</i>. Ocular perfusion pressure was calculated using the formula: 2/3[diastolic BP + 1/3 (systolic BP - diastolic BP)] - IOP.</p><p><strong>Results: </strong>Every eligible patient having dialysis was approached, and 105 eyes of 54 patients were recruited for the study. The glaucoma cohort included 19 eyes from 11 patients. The variability in IOP from the beginning to the end of HD (<i>end-before</i>) was 1.54 mmHg greater in the glaucoma group (p=0.005), with some glaucoma patients having IOP increases up to 25 mmHg. Ocular perfusion pressure decreased significantly more in glaucoma patients compared to controls at both <i>middle-before</i> (p=0.008), and <i>end-before</i> (p=0.01) time points.</p><p><strong>Conclusion: </strong>Glaucoma patients may be more vulnerable to IOP swings and drops in OPP during HD sessions compared to controls. In all cases, these changes were asymptomatic, potentially placing glaucoma patients at increased risk for glaucomatous progression during each HD session. Our results suggest that HD may be an independent risk factor for glaucomatous progression, and may be especially worth investigating in patients with progression despite low to normal IOPs measured in clinic.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"827-834"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910924/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ophthalmology (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OPTH.S513421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Prospective study to determine if patients with glaucoma are at increased risk of intraocular pressure (IOP) fluctuation and changes in ocular perfusion pressure (OPP) during hemodialysis (HD) sessions when compared to patients without glaucoma.

Patients and methods: Patients undergoing HD at the University of Iowa for end-stage renal disease were recruited. Enrollment was restricted to patients undergoing standard HD sessions for a minimum of three months. Hand-held slit lamp examination, IOP, blood pressure (BP), and central corneal thickness (CCT) measures were taken at the following three time points: the beginning of the session (before), at the half-way point (middle), and at the conclusion of the session (end). Ocular perfusion pressure was calculated using the formula: 2/3[diastolic BP + 1/3 (systolic BP - diastolic BP)] - IOP.

Results: Every eligible patient having dialysis was approached, and 105 eyes of 54 patients were recruited for the study. The glaucoma cohort included 19 eyes from 11 patients. The variability in IOP from the beginning to the end of HD (end-before) was 1.54 mmHg greater in the glaucoma group (p=0.005), with some glaucoma patients having IOP increases up to 25 mmHg. Ocular perfusion pressure decreased significantly more in glaucoma patients compared to controls at both middle-before (p=0.008), and end-before (p=0.01) time points.

Conclusion: Glaucoma patients may be more vulnerable to IOP swings and drops in OPP during HD sessions compared to controls. In all cases, these changes were asymptomatic, potentially placing glaucoma patients at increased risk for glaucomatous progression during each HD session. Our results suggest that HD may be an independent risk factor for glaucomatous progression, and may be especially worth investigating in patients with progression despite low to normal IOPs measured in clinic.

血液透析对青光眼患者的影响。
目的:前瞻性研究,确定青光眼患者在血液透析(HD)期间眼压(IOP)波动和眼灌注压(OPP)变化的风险是否比非青光眼患者更高。患者和方法:在爱荷华大学接受HD治疗的终末期肾病患者被招募。入组仅限于接受标准HD治疗至少3个月的患者。手持式裂隙灯检查、IOP、血压(BP)和角膜中央厚度(CCT)测量在以下三个时间点:治疗开始(前)、治疗中途(中)和治疗结束(结束)。眼灌注压计算公式为:2/3[舒张压+ 1/3(收缩压-舒张压)]- IOP。结果:每一个符合条件的透析患者都进行了接触,并招募了54名患者的105只眼睛进行研究。青光眼队列包括来自11名患者的19只眼睛。青光眼组从HD开始到结束(结束前)的IOP变异性比HD组高1.54 mmHg (p=0.005),一些青光眼患者的IOP升高高达25 mmHg。青光眼患者的眼灌注压在治疗前中期(p=0.008)和治疗前末期(p=0.01)时间点均明显高于对照组。结论:与对照组相比,青光眼患者在HD期间更容易受到IOP波动和OPP下降的影响。在所有病例中,这些变化都是无症状的,这可能使青光眼患者在每次HD期间青光眼进展的风险增加。我们的研究结果表明,HD可能是青光眼进展的独立危险因素,尤其值得对临床测量的低至正常IOPs进展的患者进行研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信